Class information for:
Level 1: RUN IN//RUN IN PERIOD//EFFECT MODEL

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
28502 205 23.5 51%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
1 4 ECONOMICS//EDUCATION & EDUCATIONAL RESEARCH//PSYCHOL 3876184
223 3       MEDICAL INFORMATICS//JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION//HEALTH CARE SCIENCES & SERVICES 49734
1009 2             EVIDENCE BASED MEDICINE//PUBLICATION BIAS//RESEARCH SYNTHESIS METHODS 10325
28502 1                   RUN IN//RUN IN PERIOD//EFFECT MODEL 205

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 RUN IN authKW 412479 3% 46% 6
2 RUN IN PERIOD authKW 340461 2% 57% 4
3 EFFECT MODEL authKW 335137 3% 38% 6
4 INFORMATION ON THERAPEUTICS authKW 297906 1% 100% 2
5 PERTINENT INFORMATION authKW 297906 1% 100% 2
6 THERAPY TARGET POPULATION authKW 297906 1% 100% 2
7 UNITE PHARM CLIN address 297906 1% 100% 2
8 THERAPEUTIC INFORMATION authKW 223427 1% 50% 3
9 ABSOLUTE THERAPEUTIC BENEFIT authKW 148953 0% 100% 1
10 AT RISK DISCOURSE authKW 148953 0% 100% 1

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 Pharmacology & Pharmacy 862 39% 0% 79
2 Medical Informatics 522 6% 0% 13
3 Medicine, General & Internal 243 17% 0% 35
4 Public, Environmental & Occupational Health 164 13% 0% 26
5 Health Care Sciences & Services 71 4% 0% 9
6 Peripheral Vascular Diseases 63 6% 0% 12
7 Mathematical & Computational Biology 59 3% 0% 7
8 Women’s Studies 43 1% 0% 3
9 Medicine, Research & Experimental 40 6% 0% 13
10 Statistics & Probability 39 4% 0% 8

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 UNITE PHARM CLIN 297906 1% 100% 2
2 CIC P PHARMACOL SERV 0005 148953 0% 100% 1
3 DIRECT CLIN DEV 148953 0% 100% 1
4 MD ANDERSON CANCER BEHAV SCI 148953 0% 100% 1
5 MED RTH LAENNECSERV PHARMACOL CLIN 148953 0% 100% 1
6 PHISQUARE 148953 0% 100% 1
7 RECH INGN CONNAISSANCES PL THER EUT 148953 0% 100% 1
8 RTH LEANNEC MED 148953 0% 100% 1
9 SERV PHARMACOL CLIN EA3736 148953 0% 100% 1
10 SERV PHARMACOL CLIN EA643 148953 0% 100% 1

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 CONTROLLED CLINICAL TRIALS 81188 11% 2% 23
2 THERAPIE 76080 18% 1% 36
3 REVUE DU PRATICIEN 4864 2% 1% 5
4 FUNDAMENTAL & CLINICAL PHARMACOLOGY 1826 2% 0% 5
5 DIALOGUE-CANADIAN PHILOSOPHICAL REVIEW 1717 1% 0% 3
6 REVUE D EPIDEMIOLOGIE ET DE SANTE PUBLIQUE 1430 2% 0% 4
7 EPIDEMIOLOGIA E PSICHIATRIA SOCIALE-AN INTERNATIONAL JOURNAL FOR EPIDEMIOLOGY AND PSYCHIATRIC SCIENCES 1032 0% 1% 1
8 STATISTICS IN MEDICINE 1009 3% 0% 7
9 JOURNAL OF CHRONIC DISEASES 774 1% 0% 2
10 COMPUTERS AND BIOMEDICAL RESEARCH 711 1% 0% 2

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 RUN IN 412479 3% 46% 6 Search RUN+IN Search RUN+IN
2 RUN IN PERIOD 340461 2% 57% 4 Search RUN+IN+PERIOD Search RUN+IN+PERIOD
3 EFFECT MODEL 335137 3% 38% 6 Search EFFECT+MODEL Search EFFECT+MODEL
4 INFORMATION ON THERAPEUTICS 297906 1% 100% 2 Search INFORMATION+ON+THERAPEUTICS Search INFORMATION+ON+THERAPEUTICS
5 PERTINENT INFORMATION 297906 1% 100% 2 Search PERTINENT+INFORMATION Search PERTINENT+INFORMATION
6 THERAPY TARGET POPULATION 297906 1% 100% 2 Search THERAPY+TARGET+POPULATION Search THERAPY+TARGET+POPULATION
7 THERAPEUTIC INFORMATION 223427 1% 50% 3 Search THERAPEUTIC+INFORMATION Search THERAPEUTIC+INFORMATION
8 ABSOLUTE THERAPEUTIC BENEFIT 148953 0% 100% 1 Search ABSOLUTE+THERAPEUTIC+BENEFIT Search ABSOLUTE+THERAPEUTIC+BENEFIT
9 AT RISK DISCOURSE 148953 0% 100% 1 Search AT+RISK+DISCOURSE Search AT+RISK+DISCOURSE
10 AVAILABLE EVIDENCE 148953 0% 100% 1 Search AVAILABLE+EVIDENCE Search AVAILABLE+EVIDENCE

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref.
in cl.		 Shr. of ref. in
cl.		 Citations
1 KAHOUL, R , GUEYFFIER, F , AMSALLEM, E , HAUGH, M , MARCHANT, I , BOISSEL, FH , BOISSEL, JP , (2014) COMPARISON OF AN EFFECT-MODEL-LAW-BASED METHOD VERSUS TRADITIONAL CLINICAL PRACTICE GUIDELINES FOR OPTIMAL TREATMENT DECISION-MAKING: APPLICATION TO STATIN TREATMENT IN THE FRENCH POPULATION.JOURNAL OF THE ROYAL SOCIETY INTERFACE. VOL. 11. ISSUE 100. P. - 10 53% 0
2 ULMER, M , ROBINAUGH, D , FRIEDBERG, JP , LIPSITZ, SR , NATARAJAN, S , (2008) USEFULNESS OF A RUN-IN PERIOD TO REDUCE DROP-OUTS IN A RANDOMIZED CONTROLLED TRIAL OF A BEHAVIORAL INTERVENTION.CONTEMPORARY CLINICAL TRIALS. VOL. 29. ISSUE 5. P. 705-710 10 38% 13
3 MASSOL, J , BOISSEL, JP , (2014) BETTER DEFINING TARGET POPULATIONS FOR DRUGS WITH A VIEW TO REIMBURSEMENT.THERAPIE. VOL. 69. ISSUE 3. P. 235 -237 4 80% 0
4 BOISSEL, JP , (1997) TARGET POPULATION FOR ANTIHYPERTENSIVE THERAPY..ARCHIVES DES MALADIES DU COEUR ET DES VAISSEAUX. VOL. 90. ISSUE . P. 31-34 5 100% 0
5 GUEYFFIER, F , BOISSEL, JP , CUCHERAT, M , (1996) INTEGRATABLE MESSAGE: A CENTRAL COMMUNICATION ISSUE FOR THERAPEUTIC INFORMATION.THERAPIE. VOL. 51. ISSUE 3. P. 240-245 8 62% 1
6 BOISSEL, JP , KAHOUL, R , AMSALLEM, E , GUEYFFIER, F , HAUGH, M , BOISSEL, FH , (2011) TOWARDS PERSONALIZED MEDICINE: EXPLORING THE CONSEQUENCES OF THE EFFECT MODEL-BASED APPROACH.PERSONALIZED MEDICINE. VOL. 8. ISSUE 5. P. 581-586 6 46% 1
7 BOISSEL, JP , (2007) META-ANALYSIS OF CLINICAL TRIALS: USES AND PITFALLS.BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE. VOL. 191. ISSUE 4-5. P. 759-770 6 46% 0
8 BEN ABDELAZIZ, A , HARRABI, I , RAHMANI, S , GAHA, R , GHANNEM, H , (2002) CIRCULATION OF PHARMACEUTICAL INFORMATION AMONG GENERAL PRACTIONERS IN THE REGION OF SOUSSE (TUNISIA).THERAPIE. VOL. 57. ISSUE 3. P. 229-235 5 63% 0
9 BOISSEL, JP , (1996) CONSEQUENCES OF DEPARTURE OF DOCTORS' PRESCRIPTIONS FROM AVAILABLE EVIDENCE.THERAPIE. VOL. 51. ISSUE 3. P. 225-232 8 47% 3
10 BOISSEL, JP , HAUGH, M , FARDEHEB, M , NONY, P , GUEYFFIER, F , STRANG, N , (2003) HOW SHOULD THERAPEUTIC INFORMATION BE TRANSFERRED TO USERS?.FUNDAMENTAL & CLINICAL PHARMACOLOGY. VOL. 17. ISSUE 4. P. 495-503 12 23% 2

Classes with closest relation at Level 1


Rank Class id link
1 31893 CORONARY ANGIOGRAPHY AND INTERVENTION//DOSE ADVERSE EVENT RELATIONSHIP//DOSE LIMITING ADVERSE EFFECTS
2 22840 ACADEMIC DETAILING//EDUCATIONAL OUTREACH VISITS//MAILED FEEDBACK
3 31820 ALVERINE//THERAPIE//ASSOC FRANCAISE REGIONAUX PHARMACOVIGILANCE
4 11124 NUMERACY//RISK COMMUNICATION//RISK LITERACY
5 23681 MEDICINE USE//FKL//INFORMAT LEARNING OURCE SERV
6 6626 MEDLINE//EMBASE//LITERATURE SEARCHING
7 35971 VALORIZAT SUPPORT SPACE//AMERICAN ASSOCIATION OF CARDIOVASCULAR AND PULMONARY REHABILITATION//ANGIOTENSIN 1 CONVERTING ENZYME ACE 1
8 21270 JOURNAL OF EVALUATION IN CLINICAL PRACTICE//MEDICAL EPISTEMOLOGY//EVIDENCE BASED MEDICINE
9 37109 ANIMAL DERIVED MEDICAL DEVICE//DIRECC INFORMAC CIENTIF//HEALTH INFORMATION TECHNOLOGY ELECTRONIC HEALTH RECORDS
10 36325 ACETIL SALICILIC ACID//AGENCIA EVALUAT TECNOL SANITARIAS//BERTHA HARMER

Go to start page